170 related articles for article (PubMed ID: 22505463)
1. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study.
Rachas A; Raffaitin C; Barberger-Gateau P; Helmer C; Ritchie K; Tzourio C; Amouyel P; Ducimetière P; Empana JP
Heart; 2012 Apr; 98(8):650-5. PubMed ID: 22505463
[TBL] [Abstract][Full Text] [Related]
2. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease.
Zhang Y; Hong J; Gu W; Gui M; Chen Y; Zhang Y; Chi Z; Wang W; Li X; Ning G
Endocrine; 2009 Oct; 36(2):233-8. PubMed ID: 19618299
[TBL] [Abstract][Full Text] [Related]
3. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study.
Esteghamati A; Hafezi-Nejad N; Sheikhbahaei S; Heidari B; Zandieh A; Ebadi M; Nakhjavani M
J Clin Lipidol; 2014; 8(3):279-86. PubMed ID: 24793349
[TBL] [Abstract][Full Text] [Related]
4. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
Ramezankhani A; Azizi F; Hadaegh F
Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
[TBL] [Abstract][Full Text] [Related]
6. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
[TBL] [Abstract][Full Text] [Related]
7. Disability and incident coronary heart disease in older community-dwelling adults: the Three-City Study.
Plichart M; Barberger-Gateau P; Tzourio C; Amouyel P; Pérès K; Ritchie K; Jouven X; Ducimetière P; Empana JP
J Am Geriatr Soc; 2010 Apr; 58(4):636-42. PubMed ID: 20345869
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
[TBL] [Abstract][Full Text] [Related]
11. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.
Straczek C; Ducimetiere P; Barberger-Gateau P; Helmer C; Ritchie K; Jouven X; Carcaillon L; Amouyel P; Tzourio C; Empana JP
J Am Geriatr Soc; 2010 Jan; 58(1):129-35. PubMed ID: 20002508
[TBL] [Abstract][Full Text] [Related]
12. Dynapenic Abdominal Obesity as a Risk Factor for Metabolic Syndrome in Individual 50 Years of Age or Older: English Longitudinal Study of Ageing.
Ramírez PC; de Oliveira Máximo R; Capra de Oliveira D; de Souza AF; Marques Luiz M; Bicigo Delinocente ML; Steptoe A; de Oliveira C; da Silva Alexandre T
J Nutr Health Aging; 2023; 27(12):1188-1195. PubMed ID: 38151869
[TBL] [Abstract][Full Text] [Related]
13. Prognostic interactions between cardiovascular risk factors.
Vishram JK
Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
15. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
[TBL] [Abstract][Full Text] [Related]
16. Depressive symptoms, antidepressants and disability and future coronary heart disease and stroke events in older adults: the Three City Study.
Péquignot R; Tzourio C; Péres K; Ancellin ML; Perier MC; Ducimetière P; Empana JP
Eur J Epidemiol; 2013 Mar; 28(3):249-56. PubMed ID: 23338904
[TBL] [Abstract][Full Text] [Related]
17. HDL cholesterol predicts coronary heart disease mortality in older persons.
Corti MC; Guralnik JM; Salive ME; Harris T; Field TS; Wallace RB; Berkman LF; Seeman TE; Glynn RJ; Hennekens CH
JAMA; 1995 Aug; 274(7):539-44. PubMed ID: 7629981
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome, its components, and mortality in the elderly.
Akbaraly TN; Kivimaki M; Ancelin ML; Barberger-Gateau P; Mura T; Tzourio C; Touchon J; Ritchie K; Berr C
J Clin Endocrinol Metab; 2010 Nov; 95(11):E327-32. PubMed ID: 20810578
[TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
20. Is measurement of non-HDL cholesterol an effective way to identify the metabolic syndrome?
Liu A; Reaven GM
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1122-7. PubMed ID: 23352957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
